E-LIB Suche - Ergebnisse für: Vandenborne, K.

1

P36 Givinostat in Duchenne muscular dystrophy: effect on di..:

McDonald, C. ; Servais, L. ; Munell, F....
Neuromuscular Disorders. 33 (2023) - p. S106 , 2023

Link: https://doi.org/10.1016/..

2

P132 Quantifying skeletal muscle fat fraction and function ..:

Rock, K. ; Willcocks, R. ; Forbes, S....
Neuromuscular Disorders. 33 (2023) - p. S80 , 2023

Link: https://doi.org/10.1016/..

3

P134 Energetics and acid-base status of skeletal muscle at ..:

Awale, P. ; Lopez, C. ; Taivassalo, T....
Neuromuscular Disorders. 33 (2023) - p. S81 , 2023

Link: https://doi.org/10.1016/..

4

P129 Givinostat in DMD: results of the Epidys study with pa..:

Vandenborne, K. ; Willcocks, R. ; Walter, G....
Neuromuscular Disorders. 33 (2023) - p. S79-S80 , 2023

Link: https://doi.org/10.1016/..

5

PCR28 Characterization of Patients with Duchenne Muscular D..:

Muntoni, F. ; Goemans, N. ; Posner, N....
Value in Health. 26 (2023) 6 - p. S316-S317 , 2023

Link: https://doi.org/10.1016/..

6

P151 Serum adipokines in Duchenne muscular dystrophy: relat..:

Barnard, A. ; Ikelaar, N. ; Kan, H....
Neuromuscular Disorders. 33 (2023) - p. S85-S86 , 2023

Link: https://doi.org/10.1016/..

7

O.13 Givinostat in DMD: results of the Epidys Study:

Mercuri, E. ; Vilchez, J. ; Boespflug-Tanguy, O....
Neuromuscular Disorders. 32 (2022) - p. S95-S96 , 2022

Link: https://doi.org/10.1016/..

8

P.68 Validation of a composite prognostic score for time to..:

McDonald, C. ; Gordish-Dressman, H. ; Signorovitch, J....
Neuromuscular Disorders. 32 (2022) - p. S69 , 2022

Link: https://doi.org/10.1016/..

9

VP.85 C-Path's Duchenne Regulatory Science Consortium: Acce..:

Belfiore-Oshan, R. ; Aggarwal, V. ; Sivakumaran, S....
Neuromuscular Disorders. 32 (2022) - p. S128 , 2022

Link: https://doi.org/10.1016/..

10

P.29 Accelerating clinical development of new therapeutics ..:

McDonald, C. ; Ward, S. ; Signorovitch, J....
Neuromuscular Disorders. 32 (2022) - p. S53-S54 , 2022

Link: https://doi.org/10.1016/..

11

P.69 Minimum clinically important difference in magnetic re..:

Willcocks, R. ; Barnard, A. ; Forbes, S....
Neuromuscular Disorders. 32 (2022) - p. S69-S70 , 2022

Link: https://doi.org/10.1016/..

12

DMD/BMD – OUTCOME MEASURES:

Muntoni, F. ; Signorovitch, J. ; Sajeev, G....
Neuromuscular Disorders. 31 (2021) - p. S87 , 2021

Link: https://doi.org/10.1016/..

13

MUSCLE IMAGING – MRI:

Vandenborne, K. ; Kim, S. ; Willcocks, R....
Neuromuscular Disorders. 30 (2020) - p. S93-S94 , 2020

Link: https://doi.org/10.1016/..

14

DMD & BMD – CLINICAL:

Goemans, N. ; McDonald, C. ; Signorovitch, J....
Neuromuscular Disorders. 30 (2020) - p. S63-S64 , 2020

Link: https://doi.org/10.1016/..

15

DMD – THERAPY:

Finanger, E. ; Finkel, R. ; Tennekoon, G....
Neuromuscular Disorders. 30 (2020) - p. S129 , 2020

Link: https://doi.org/10.1016/..